← signals
2026-08-10·INTC·partnership
lowup

Manifold prediction markets are pricing several Intel foundry outcomes.

Manifold prediction markets are pricing several Intel foundry outcomes.

window 60devidence 4confidence score 91price INTC $97.52

confidence score

Strong evidence: 1 independent source class support this read.

91
low confidence1 independent source classesmarketpasses publish gate
priced-in check

INTC has not made a large direction-matching 30-90 day move yet.

not priced in
as of 2026-08-107d n/a45d n/a90d -19%yahoo

signal brief

Manifold prediction markets are pricing several Intel foundry outcomes. The most notable is a formal Tesla-Intel partnership for an AI chip fab by June 30, 2026, which traders place at 96.54%. A TSMC-Intel joint-venture foundry is at 48.73%, while Intel manufacturing NVIDIA chips by end-2026 is only 27% and Intel lithography catching TSMC by 2028 is 14%. If the Tesla fab deal closes, it would validate Intel's foundry roadmap and add a marquee AI customer, a clear positive for Intel's turnaround. The TSMC JV probability near 50% suggests meaningful M&A/co-op speculation. The low NVIDIA manufacturing odds temper the bull case; Intel is not yet seen as a mainstream AI foundry partner. Still, the high-confidence Tesla probability is an actionable early indicator of partnership momentum. The main risk is that Manifold markets can be thin or speculative; this is a low-confidence signal until an official announcement appears.

What the sources said:

  • "Manifold consensus on 'Tesla announces formal Intel partnership for AI chip fab by June 30, 2026': YES=96.54%" (source)
  • "Manifold consensus on 'Will there be a joint venture chip foundry between TSMC and Intel?': YES=48.73%" (source)
  • "Manifold consensus on 'Will Intel manufacture NVIDIA chips by the end of 2026?': YES=27.00%" (source)
  • "Manifold consensus on 'Will Intel's lithography catch up with TSMC by 2028?': YES=14.03%" (source)

source data used

spillover entities

Decision support, not stock advice. This signal is research with cited evidence — not a recommendation to buy, sell, or hold any security.